Literature DB >> 20234978

[Proliferative vitreoretinopathy--pathogenesis and therapy].

I Iandiev1, A Bringmann, P Wiedemann.   

Abstract

Proliferative vitreoretinopathy (PVR) is the most important complication of retinal detachment and vitreoretinal surgery. PVR is considered to represent a maladapted retinal wound repair process; proliferation of retinal and immune cells induces the formation of epiretinal membranes which cause tractional retinal detachment. This publication gives a brief overview on the pathogenesis and operative treatment of PVR as well as on adjunct pharmacological therapy which may target the components of the proliferative process. At the moment surgical approaches are the first choice for the treatment of PVR. Scleral buckling provides good anatomic results in the treatment of a PVR stage B or C1 / C2. From stage C 3 onwards vitrectomy offers advantage. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Year:  2010        PMID: 20234978     DOI: 10.1055/s-0029-1245300

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial.

Authors:  Fritz Koerner; Ursula Koerner-Stiefbold; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-21       Impact factor: 3.117

Review 2.  [The role of the vitreous body in diseases of neighboring structures].

Authors:  K Gekeler; S Priglinger; F Gekeler; C Priglinger
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

Review 3.  [Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy].

Authors:  F Schaub; S Fauser; B Kirchhof; A Witte; R Hörster
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

Review 4.  [Pharmacological approach to treatment of proliferative vitreoretinopathy].

Authors:  C S Priglinger; S Priglinger
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

5.  Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy.

Authors:  Brijesh Takkar; Shreyas Temkar; Nripen Gaur; Pradeep Venkatesh; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.